SAN DIEGO (AP) — SAN DIEGO (AP) — Neurocrine Biosciences Inc. (NBIX) on Tuesday reported first-quarter net income of $197.9 million.
On a per-share basis, the San Diego-based company said it had net income of $1.91. Earnings, adjusted for one-time gains and costs, came to $1.94 per share.
The results surpassed Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for earnings of $1.68 per share.
The biopharmaceutical company posted revenue of $814.5 million in the period, which also topped Street forecasts. Nine analysts surveyed by Zacks expected $741.8 million.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on NBIX at https://www.zacks.com/ap/NBIX
Copyright © 2026 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.
